BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 22481518)

  • 21. A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials.
    Lang AE
    Mov Disord; 2011 Apr; 26(5):775-83. PubMed ID: 21484865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonmotor manifestations of Parkinson's disease.
    Simuni T; Sethi K
    Ann Neurol; 2008 Dec; 64 Suppl 2():S65-80. PubMed ID: 19127582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms.
    Prediger RD
    J Alzheimers Dis; 2010; 20 Suppl 1():S205-20. PubMed ID: 20182024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Premotor diagnosis of Parkinson's disease].
    Morales-Briceño H; Cervantes-Arriaga A; Rodríguez-Violante M
    Gac Med Mex; 2011; 147(1):22-32. PubMed ID: 21412393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premotor symptoms and early diagnosis of Parkinson's disease.
    Adler CH
    Int J Neurosci; 2011; 121 Suppl 2():3-8. PubMed ID: 22035024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
    Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-motor dysfunction in Parkinson's disease.
    Ziemssen T; Reichmann H
    Parkinsonism Relat Disord; 2007 Aug; 13(6):323-32. PubMed ID: 17349813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood disorders in Parkinson's disease.
    Tan LC
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S74-6. PubMed ID: 22166461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for the diagnosis and management of Parkinson's disease.
    Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M
    Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition and management of Parkinson's disease during the premotor (prodromal) phase.
    Truong DD; Wolters EC
    Expert Rev Neurother; 2009 Jun; 9(6):847-57. PubMed ID: 19496688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and assessment of psychopathological symptoms in Parkinson's disease].
    Reijnders JS; Leentjens AF
    Tijdschr Psychiatr; 2011; 53(9):679-84. PubMed ID: 21898328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Parkinson's disease - why, when, and how?
    Postuma RB; Montplaisir J
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S105-9. PubMed ID: 20082967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.
    Pacchetti C; Manni R; Zangaglia R; Mancini F; Marchioni E; Tassorelli C; Terzaghi M; Ossola M; Martignoni E; Moglia A; Nappi G
    Mov Disord; 2005 Nov; 20(11):1439-48. PubMed ID: 16028215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early diagnosis of Parkinson's disease: recommendations from diagnostic clinical guidelines.
    Pahwa R; Lyons KE
    Am J Manag Care; 2010 Mar; 16 Suppl Implications():S94-9. PubMed ID: 20297872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is pre-motor diagnosis possible? The European experience.
    Berg D
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S195-8. PubMed ID: 22166433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
    Liepelt-Scarfone I; Gauss K; Maetzler W; Müller K; Bormann C; Fruhmann Berger M; Timmers M; Streffer J; Berg D
    Neuroepidemiology; 2013; 41(3-4):174-82. PubMed ID: 24051361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications.
    Akhtar RS; Stern MB
    Expert Rev Neurother; 2012 Dec; 12(12):1429-38. PubMed ID: 23237350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.
    Bang Y; Lim J; Choi HJ
    Arch Pharm Res; 2021 Jun; 44(6):588-604. PubMed ID: 34145553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.